Role for NADPH/NADH oxidase in the modulation of vascular tone

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 386-400

  Münzel, Thomas ^a   Hink, Ulrich ^a   Heitzer, Thomas ^a   Meinertz, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; FREE RADICAL; NITRIC OXIDE; OXYGEN; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ATHEROSCLEROSIS; BLOOD VESSEL TONE; CONFERENCE PAPER; HYPERTENSION; NEUTROPHIL; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0032780507     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09253.x     Document Type: Conference Paper

References (47)

1. 1. BEVILACQUA, M.P. 1993. Endothelial-leucocyte adhesion molecules. Annu. Rev. Immunol. 11: 767-804.
2. 2. MYERS, P.R., R.L. MINOR, JR., R. GUERRA, JR., J.N. BATES & D.G. HARRISON. 1990. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163.
3. 3. PALMER, R.M. J., D.S. ASHTON & S. MONCADA. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
4. 4. GRYGLEWSKI, R.J., R.M.J. PALMER & S. MONCADA. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456.
5. 5. BECKMAN, J.S., T.W. BECKMAN, J. CHEN, P.A. MARSHALL & B.A. FREEMAN. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
6. 6. MUNZEL, T., S. KURZ, S. RAJAGOPALAN, M. TARPEY, B. FREEMAN & D.G. HARRISON. 1995. Identification of the membrane bound NADH oxidase as the major source of superoxide anion in nitrate tolerance. Endothelium 3(Suppl): s14(abstract).
7. 7. MUNZEL, T., S. KURZ, S. RAJAGOPALAN, M. THOENES, W.R. BERRINGTON, J.A. THOMPSON, B.A. FREEMAN & D.G. HARRISON. 1996. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J. Clin. Invest. 98: 1465-1470.
8. 8. MOHAZZAB, H.K.M., P.M. KAMINSKI & M.S. WOLIN. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary endothelium. Am. J. Physiol. 266: H2568-H2572.
9. 9. GRIENDLING, K.K., C.A. MINIERI, J.D. OLLERENSHAW & R.W. ALEXANDER. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74: 1141-1148.
10. 10. RAJAGOPALAN, S., S. KURZ, T. MUNZEL, M. TARPEY, B.A. FREEMAN, K.K. GRIENDLING & D.G. HARRISON. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97: 1916-1923.
11. 11. FURCHGOTT, R.F. & J.V. ZAWADZKI. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 228: 373-376.
12. 12. PALMER, R.M., A.G. FERRIGE & S. MONCADA. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
13. 13. RADOMSKI, M.W., R.M. PALMER & S. MONCADA. 1987. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92: 639-646.
14. 14. GARG, U.C. & A. HASSID. 1989. Nitric oxide - generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777.
15. 15. LIU, S., J.S. BECKMAN & D.D. KU. 1994. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J. Pharmacol. Exp. Ther. 268: 1114-11121.
16. 16. RUBBO, H., R. RADI, M. TRUJILLO, R. TELLERI, B. KALYANARAMAN, S. BARNES, M. KIRK & B.A. FREEMAN. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269: 26066-26075.
17. 17. RADI, R., J.S. BECKMAN, K.M. BUSH & B.A. FREEMAN. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487.
18. 18. RADI, R., J.S. BECKMAN, K.M. BUSH & B.A. FREEMAN. 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266: 4244-4250.
19. 19. WHITE, C.R., V. DARLEY-USMAR, W.R. BERRINGTON, M. MCADAMS, J.Z. GORE, J.A. THOMPSON, D.A. PARKS, M.M. TARPEY & B.A. FREEMAN. 1996. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. USA 93: 8745-8749.
20. 20. USHIO-FUKAI, M., A.M. ZAFARI, T. FUKUI, N. ISHIZAKA & K.K. GRIENDLING. 1996. p22phox is a critical component of the superoxide generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271: 23317-23321.
21. 21. MOHAZZAB, K.M., P.M. KAMINSKI & M.S. WOLIN. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266: H2568-H2572.
22. 22. LANG, D., A.C. SHAKESBY, S. MOSFER & M.J. LEWIS. 1997. Angiotensin II upregulates NADH/NADPH oxidase mediated superoxide anion production by guinea pig coronary mircovascular endothelial cells. Circulation 96: I-44.
23. 23. HOWARD, A.B., R.W. ALEXANDER, R.M. NEREM, K.K. GRIENDLING & W.R. TAYLOR. 1997. Cyclic strain induces an oxidative stress in endothelial cells. Am. J. Physiol. 272: C421-427.
24. 24. BASTIAN, N.R. & J. HIBBS, JR. 1994. Assembly and regulation of NADPH oxidase and nitric oxide synthase. [Review]. Curr. Opinion Immunol. 6: 131-139.
25. 25. DUSI, S., V. DELLA-BIANCA, M. GRZESKOWIAK & F. ROSSI. 1993. Relationship between phosphorylation and translocation to the plasma membrane of p47phox and p67phox and activation of the NADPH oxidase in normal and Ca(2+)-depleted human neutrophils. Biochem. J. 290: 173-178.
26. 26. JONES, S.A., V.B. O'DONNELL, J.D. WOOD, J.P. BROUGHTON, E.J. HUGHES & O.T.G. JONES. 1996. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271: H1626-H1634.
27. 27. FUKUI, T., B. LASSEGUE, H. KAI, R.W. ALEXANDER & K.K. GRIENDLING. 1995. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim. Biophys. Acta 1231: 215-219.
28. 28. WANG, H.D., J. PAGANO, Y. DU, A.J. CAYATTE, M.T. QUINN, P. BRECHER & R.A. COHEN. 1998. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ. Res. 82: 810-818.
29. 29. FUKUI, T., N. ISHIZAKA, S. RAJAGOPALAN, J.B. LAURSEN, Q. CAPERS IV, W.R. TAYLER, D.G. HARRISON, H. DE LEON, J.N. WILCOX & K.K. GRIENDLING. 1997. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80: 45-51.
30. 30. LAURSEN, J.B., S. RAJAGOPALAN, Z. GALIS, M. TARPEY, B.A. FREEMAN & D.G. HARRISON. 1997. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension [see comments]. Circulation 95: 588-593.
31. 31. HEITZER, T., U. WENZEL, U. HINK, D. KROLLNER, M. SKATCHKOV, R.A.K. STAHL, R. MACHARZINA, T. MEINERTZ & T. MÜNZEL. 1999. Increased NAD(P)H oxidase mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney International. 55: 252-260.
32. 32. PAGANO, P.J., J.K. CLARK, M.E. CIFUENTES-PAGANO, S.M. CLARK, G.M. CALLIS & M.T. QUINN. 1997. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. USA 94: 14483-14488.
33. 33. INOUE, N., S. KAWASHIMA, K. KANAZAWA, S. YAMADA, H. AKITA & M. YOKOYAMA. 1998. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97: 135-137.
34. 34. ABRAMS, J. 1988. A reappraisal of nitrate therapy. [Review]. J. Am. Med. Assoc. 259: 396-401.
35. 35. ROTH, A., D. KULICK, L. FREIDENBERGER, R. HONG, S.H. RAHIMTOOLA & U. ELKAYAM. 1987. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure. J. Am. Coll. Cardiol. 9: 858-864.
36. 36. MUNZEL, T., T. HEITZER, S. KURZ, D.G. HARRISON, C. LUHMAN, L. PAPE, M. OLSCHEWSKI & H. JUST. 1996. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J. Am. Coll. Cardiol. 27: 297-303.
37. 37. MUNZEL, T., H. SAYEGH, B.A. FREEMAN, M M. TARPEY & D.G. HARRISON. 1995. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95: 187-194.
38. 38. MUNZEL, T., T. HEITZER, R. MACHARZINA, U. RÜCKSCHLOSS, H. MORAWETZ, D. DARMER & J. HOLTZ. 1997. Nitrat-Toleranz durch chronische Nitroglyzeringabe führt zu veränderter Expression der NAD(P)H-Oxidase Untereinheiten und zu vermehrter Superoxidanionen-Bildung im Endothel von Kaninchen. Z. Kardiol. 86: 197 (abstract).
39. 39. PIEPER, G.M. & G.J. GROSS. 1992. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc. Drugs Ther. 6: 225-232.
40. 40. PIEPER, G.M. & G.J. GROSS. 1992. EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes. Immunopharmacology 23: 191-197.
41. 41. SOHN, H.Y., M. KELLER, T. GLOE & U. POHL. 1998. Kalium-induzierte Membrande-polarisation steigert die Superoxidanionen-Produktion in humanen Endothelzellen. Z. Kardiol. 87: 105(abstract).
42. 42. MUNZEL, T., A. GIAID, S. KURZ, D.J. STEWART & D.G. HARRISON. 1995. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc. Natl. Acad. Sci. USA 92: 5244-5248.
43. 43. ZIERHUT, W. & H.A. BALL. 1996. Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C. Br. J. Pharmacol. 119: 3-5.
44. 44. MAJUMADAR, S., L.H. KANE, M.W. ROSSI, B.D. VOLPP, W.M. NAUSEEF & H.M. KORHAK. 1993. Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent β-PKC and novel calcium independent nPKC. Biochim. Biophys. Acta 1176: 276-286.
45. 45. BASSENGE, E., N. FINK, M. SKATCHKOV & B. FINK. 1998. Dietary supplement with vitamin C prevents nitrate tolerance. J. Clin. Invest. 102: 67-71.
46. 46. WATANABE, H., M. KAKIHANA, S. OHTSUKA & Y. SUGISHITA. 1997. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance. Circulation 96: 2545-2550.
47. 47. PAGANO, P.J., Y. ITO, K. TORNHEIM, P.M. GALLOP, A.I. TAUBER & R.A. COHEN. 1995. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am. J. Physiol. 268: H2274-2280.